Voloridge Investment Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-87,981
| Closed | -$478K | – | 1346 |
|
2024
Q4 | $478K | Sell |
87,981
-234,954
| -73% | -$1.28M | ﹤0.01% | 1103 |
|
2024
Q3 | $2.33M | Sell |
322,935
-106,902
| -25% | -$772K | 0.01% | 921 |
|
2024
Q2 | $4.67M | Sell |
429,837
-122,804
| -22% | -$1.33M | 0.02% | 764 |
|
2024
Q1 | $10.4M | Buy |
552,641
+159,942
| +41% | +$3M | 0.04% | 483 |
|
2023
Q4 | $8.51M | Buy |
392,699
+321,731
| +453% | +$6.97M | 0.03% | 507 |
|
2023
Q3 | $1.46M | Buy |
+70,968
| New | +$1.46M | 0.01% | 1015 |
|
2022
Q3 | – | Sell |
-132,101
| Closed | -$4.27M | – | 1596 |
|
2022
Q2 | $4.27M | Buy |
132,101
+87,661
| +197% | +$2.83M | 0.02% | 735 |
|
2022
Q1 | $1.47M | Sell |
44,440
-89,805
| -67% | -$2.97M | 0.01% | 1041 |
|
2021
Q4 | $5.71M | Sell |
134,245
-105,962
| -44% | -$4.51M | 0.03% | 674 |
|
2021
Q3 | $10.6M | Buy |
240,207
+93,661
| +64% | +$4.15M | 0.07% | 408 |
|
2021
Q2 | $8.33M | Sell |
146,546
-20,513
| -12% | -$1.17M | 0.06% | 468 |
|
2021
Q1 | $12.5M | Sell |
167,059
-7,640
| -4% | -$572K | 0.09% | 291 |
|
2020
Q4 | $15.1M | Buy |
174,699
+9,452
| +6% | +$818K | 0.13% | 197 |
|
2020
Q3 | $10.1M | Sell |
165,247
-182,106
| -52% | -$11.1M | 0.08% | 261 |
|
2020
Q2 | $14.4M | Buy |
347,353
+143,641
| +71% | +$5.97M | 0.17% | 129 |
|
2020
Q1 | $5.85M | Buy |
203,712
+187,161
| +1,131% | +$5.38M | 0.17% | 134 |
|
2019
Q4 | $1.2M | Sell |
16,551
-973
| -6% | -$70.3K | 0.02% | 600 |
|
2019
Q3 | $2.46M | Buy |
+17,524
| New | +$2.46M | 0.04% | 399 |
|
2018
Q1 | – | Sell |
-53,908
| Closed | -$8.88M | – | 633 |
|
2017
Q4 | $8.88M | Buy |
+53,908
| New | +$8.88M | 0.19% | 129 |
|
2017
Q3 | – | Sell |
-73,953
| Closed | -$5.89M | – | 516 |
|
2017
Q2 | $5.89M | Sell |
73,953
-9,400
| -11% | -$749K | 0.15% | 153 |
|
2017
Q1 | $5.92M | Buy |
83,353
+33,087
| +66% | +$2.35M | 0.14% | 179 |
|
2016
Q4 | $2.57M | Buy |
+50,266
| New | +$2.57M | 0.06% | 362 |
|